Allogeneic hematopoietic SCT in patients with non-malignant diseases, and importance of chimerism (Q83781694)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19421178%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

title

Allogeneic hematopoietic SCT in patients with non-malignant diseases, and importance of chimerism (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19421178%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19421178%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

author name string

P Svenberg

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19421178%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

O Ringdén

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19421178%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

M Uzunel

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19421178%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

publication date

4 May 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19421178%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

27 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19421178%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

volume

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19421178%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19421178%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

page(s)

757-763

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19421178%20AND%20SRC:MED&resulttype=core&format=json

Allogeneic hematopoietic stem cell transplantation for inherited disorders: experience in a single center

27 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.82

7 January 2021

Haemopoietic stem cell transplantation for genetic disorders

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.82

7 January 2021

Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.82

7 January 2021

T cell mixed chimerism is significantly correlated to a decreased risk of acute graft-versus-host disease after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.82

7 January 2021

Analysis of chimaerism in thalassaemic children undergoing stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.82

7 January 2021

Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.82

7 January 2021

Overcoming graft rejection in heavily transfused and allo-immunised patients with bone marrow failure syndromes using fludarabine-based haematopoietic cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.82

7 January 2021

Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.82

7 January 2021

Outcome in six children with mucopolysaccharidosis type IH, Hurler syndrome, after haematopoietic stem cell transplantation (HSCT).

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.82

7 January 2021

HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.82

7 January 2021

Fludarabine-based reduced intensity conditioning for stem cell transplantation of Fanconi anemia patients from fully matched related and unrelated donors.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.82

7 January 2021

Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.82

7 January 2021

Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.82

7 January 2021

A novel rapid single nucleotide polymorphism (SNP)-based method for assessment of hematopoietic chimerism after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.82

7 January 2021

Five-year follow-up of two siblings with aspartylglucosaminuria undergoing allogeneic stem-cell transplantation from unrelated donors

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.82

7 January 2021

Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.82

7 January 2021

Advances in the allogeneic transplantation for thalassemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.82

7 January 2021

Mixed chimaerism is common at the time of acute graft-versus-host disease and disease response in patients receiving non-myeloablative conditioning and allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.82

7 January 2021

Nonmyeloablative allogeneic stem cell transplant strategies and the role of mixed chimerism

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.82

7 January 2021

Chimerism analysis following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.82

7 January 2021

Mixed chimerism and graft failure following conditioning with the fludarabine and cyclophosphamide nonablative regimen; conversion to full donor chimerism.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.82

7 January 2021

Clinical relevance of serial quantitative analysis of hematopoietic chimerism after allogeneic stem cell transplantation in children for severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.82

7 January 2021

Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.82

7 January 2021

Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Societe Francaise de Greffe de Moelle (SFGM)

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.82

7 January 2021